Research Peptides · Cat. 034-90
GPR15L / C10orf99 (25-81) (Human)
Supplied as 100 µg per unit. Purity ≥ 95%. Molecular weight 6514.7. Species: Human. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 034-90 |
|---|---|
| Product type | Research Peptides |
| Peptide family | GPCR Receptor Fragment Peptides |
| Species | Human |
| Unit size | 100 µg |
| Molecular weight | 6514.7 Da |
| Purity | ≥ 95% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 100 µg of NET peptide. |
| Solubility | Soluble in water |
| Disulfide Bridge | Disulfide Bridge: Cys16-Cys39, Cys17-Cys36<br /><img src="https://phoenixpeptide.com/doc/structure/db_1to4_2to3.jpg" alt="" width="254" height="63" /> Tyrosine sulfation and O-glycosylation of chemoattractant receptor GPR15 differentially regulate interaction with GPR15L Okamoto Y, Shikano S. Tyrosine sulfation and O-glycosylation of chemoattractant receptor GPR15 differentially regulate interaction with GPR15L. J Cell Sci. 2021;134(8):jcs247833. The authors used Phoenix’s GPR15L/C10orf99 (25-81) (Human) (Cat. #034-90) for their study. Structure-activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor Deng Y, Perez Almeria CV, van Gijzel L, et al. Structure-activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor. Basic Clin Pharmacol Toxicol. 2023;132(6):459-471. The authors used Phoenix’s GPR15L/C10orf99 (25-81) (Human) (Cat. #034-90) for their study. Delineation of the GPR15 receptor-mediated Gα protein signalling profile in recombinant mammalian cells Deng Y, Moo EV, Almería CVP, et al. Delineation of the GPR15 receptor-mediated Gα protein signalling profile in recombinant mammalian cells. Basic Clin Pharmacol Toxicol. 2022;131(2):104-113. The authors used Phoenix’s GPR15L/C10orf99 (25-81) (Human) (Cat. #034-90) for their study. |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
Lys-Arg-Arg-Pro-Ala-Lys-Ala-Trp-Ser-Gly-Arg-Arg-Thr-Arg-Leu-Cys-Cys-His-Arg-Val-Pro-Ser-Pro-Asn-Ser-Thr-Asn-Leu-Lys-Gly-His-His-Val-Arg-Leu-Cys-Lys-Pro-Cys-Lys-Leu-Glu-Pro-Glu-Pro-Arg-Leu-Trp-Val-Val-Pro-Gly-Ala-Leu-Pro-Gln-Val
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. Long-term storage may form a dimerized peptide.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is GPR15L / C10orf99 (25-81) (Human)?
What purity is listed for 034-90?
How should GPR15L / C10orf99 (25-81) (Human) be stored?
What is the sequence of GPR15L / C10orf99 (25-81) (Human)?
What is the intended use of 034-90?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.